Anergic T cells actively suppress T cell responses via the antigen‐presenting cell

We here show that anergic T cells are active mediators of T cell suppression. In co‐culture experiments, we found that anergic T cells, derived from established rat T cell clones and rendered anergic via T cell presentation of the specific antigen (Ag), were active inhibitors of T cell responses. Anergic T cells inhibited not only the responses of T cells with the same Ag specificity as the anergic T cells, but were also capable of efficiently inhibiting polyclonal T cell responses directed to other epitopes. This suppression required close cell‐cell contact between antigen‐presenting cells (APC), anergic T cells and responder T cells, and only occurred when the epitope recognized by the anergic T cell was present. The suppression was not caused by passive competition for ligands on the APC surface, IL‐2 consumption, or cytolysis, and was not mediated by soluble factors derived from anergic T cells that were stimulated with their specific Ag. When responder T cells were added 24 h after co‐culturing anergic cells in the presence of Ag and APC, T cell responses were still suppressed, indicating that the suppressive effect was persistently present. However, anergic T cells were not able to suppress responder T cells that had already received a full activation signal. We propose that suppression by anergic T cells is mediated via the APC, either through modulation of the T cell‐activating capacity of the APC (APC/T cell interaction), or by inhibition of T cells recognizing their ligand in close proximity on the same APC (T/T cell interaction).

[1]  R. Lechler,et al.  Anergic T cells effect linked suppression , 1997, European journal of immunology.

[2]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[3]  S. Mohapatra,et al.  Vaccination with a multi‐epitopic recombinant allergen induces specific immune deviation via T‐cell anergy , 1997, Immunology.

[4]  Y. Kong,et al.  Regulatory T cells in maintenance and reversal of peripheral tolerance in vivo. , 1996, Journal of immunology.

[5]  S. Matsushita,et al.  Altered TCR ligands affect antigen-presenting cell responses: up-regulation of IL-12 by an analogue peptide. , 1996, Journal of immunology.

[6]  G. Riethmüller,et al.  Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro , 1996, Journal of virology.

[7]  R. Grunow,et al.  Anergy induction in human CD4+ T-cell clones by stimulation with soluble peptides does not require cell proliferation and is accompanied by elevated IL4 production. , 1996, Cellular immunology.

[8]  M. Mannie,et al.  Anergy-associated T cell antigen presentation. A mechanism of infectious tolerance in experimental autoimmune encephalomyelitis. , 1996, Journal of immunology.

[9]  R. Schwartz,et al.  Models of T Cell Anergy: Is There a Common Molecular Mechanism? , 1996 .

[10]  R. Lechler,et al.  Antigen presentation by T cells inhibits IL-2 production and induces IL-4 release due to altered cognate signals. , 1996, Journal of immunology.

[11]  A. Kruisbeek,et al.  Mechanisms underlying T-cell tolerance. , 1996, Current opinion in immunology.

[12]  C. Janeway,et al.  Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[13]  H. Weiner,et al.  Peripheral deletion of antigen-reactive T cells in oral tolerance , 1995, Nature.

[14]  M. Pender,et al.  Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: further evidence of apoptotic deletion of autoreactive T cells in the central nervous system. , 1995, International immunology.

[15]  B. Rocha,et al.  Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance , 1995, The Journal of experimental medicine.

[16]  J. Alferink,et al.  Long life span of tolerant T cells and the role of antigen in maintenance of peripheral tolerance. , 1995, International immunology.

[17]  W. van Eden,et al.  Activated rat T cells synthesize and express functional major histocompatibility class II antigens. , 1995, Immunology.

[18]  D. Lo,et al.  T cells and suppression in vitro. , 1994, Science.

[19]  T. Wyss-Coray,et al.  T cells as antigen-presenting cells. , 1994, Immunology today.

[20]  R. Lechler,et al.  Anergic T cells as suppressor cells in vitro. , 1994, Science.

[21]  J. Peterson,et al.  Anergy in vivo: down-regulation of antigen-specific CD4+ Th1 but not Th2 cytokine responses. , 1994, International immunology.

[22]  W. van Eden,et al.  Inhibition of experimental autoimmune encephalomyelitis by MHC class II binding competitor peptides depends on the relative MHC binding affinity of the disease-inducing peptide. , 1994, Journal of immunology.

[23]  W. van Eden,et al.  Differential mycobacterial 65-kDa heat shock protein T cell epitope recognition after adjuvant arthritis-inducing or protective immunization protocols. , 1994, Journal of immunology.

[24]  P. Allen Peptides in positive and negative selection: A delicate balance , 1994, Cell.

[25]  P. Allen,et al.  Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells , 1993, Nature.

[26]  D. Kioussis,et al.  "Infectious" transplantation tolerance , 1993, Science.

[27]  R. Lechler,et al.  Human T cells cannot act as autonomous antigen-presenting cells, but induce tolerance in antigen-specific and alloreactive responder cells , 1992, The Journal of experimental medicine.

[28]  G. Freeman,et al.  Early signaling defects in human T cells anergized by T cell presentation of autoantigen , 1992, The Journal of experimental medicine.

[29]  H. Waldmann,et al.  Monoclonal antibodies as agents to reinduce tolerance in autoimmunity. , 1992, Journal of autoimmunity.

[30]  H. Pircher,et al.  Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice , 1991, Cell.

[31]  J. Sprent,et al.  Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity , 1990, Cell.

[32]  R. Schwartz,et al.  Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. , 1990, Journal of immunology.

[33]  R. Schwartz,et al.  An accessory cell-derived costimulatory signal acts independently of protein kinase C activation to allow T cell proliferation and prevent the induction of unresponsiveness. , 1989, Journal of immunology.

[34]  I. Cohen,et al.  Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis , 1988, Nature.

[35]  R. Schwartz,et al.  Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness. , 1987, Journal of immunology.

[36]  R. Schwartz,et al.  Antigen presentation by chemically modified splenocytes induces antigen- specific T cell unresponsiveness in vitro and in vivo , 1987, The Journal of experimental medicine.

[37]  I. Cohen,et al.  Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II. , 1984, The Journal of clinical investigation.

[38]  J. Lamb,et al.  Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin , 1983, The Journal of experimental medicine.

[39]  I. Cohen,et al.  The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis , 1981, European journal of immunology.

[40]  R. Winchester,et al.  Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells , 1979, The Journal of experimental medicine.